Aktiia was extremely useful in trying to find an effective medication regime with my cardiologist until it became an unreliable source of data. After about three months, the frequency of readings began to decline sharply. Charging and reinitializing make no difference. I no longer get most overnight readings and daytime readings are irregular with gaps of four to six hours. Clearly, the electronics are failing (sensor, accelerometer ?). It rarely responds to the shake or tap test when it goes into these "dead" periods.A very useful device that sadly is poorly made. I am back to using my old arm cuff so I can get the needed data.The facts that Aktiia seems to offer no customer service other than a very limited bot and replies only to positive reviews should raise a red flag for prospective purchasers. After first posting this review, Aktiia provided the response below. In the response, they say to "reach out to them". I would love to get some help with the apparent mechanical failure of the device. However, Aktiia provide no means of customer service contact. All they offer is a primitive bot (really just a set of nested menus) that has the same information on their website. Absolutely no help in getting product service. You get what is in the box. If it fails, you are on your own. I have edited the title to reflect this.
Claim your business profile now and gain access to all features and respond to customer reviews.
Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed.
Hilo is transforming blood pressure monitoring with cuffless, AI-powered technology that delivers continuous, accessible insights for individuals and healthcare professionals. Our foundation model is trained on billions of optical signals and hundreds of millions of readings from over 120,000 users—one of the largest datasets in the field. Backed by a multidisciplinary team with deep expertise in biomedical signal processing, Hilo has contributed to over 120 peer-reviewed publications and holds more than 35 patents. Headquartered in Switzerland, we’re expanding globally to redefine how blood pressure is measured and managed.See more
